Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice

Psychopharmacology

Volumn 191, Issue 4, 2007, Pages 985-993

  Carrigan, Kelly A ^a   Dykstra, Linda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Acetylcholine; Antinociception; Cocaine; Conditioned place preference; Knockout; M1 receptor; Morphine; Muscarinic

Indexed keywords

COCAINE; MORPHINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; C57BL 6 MOUSE; CHRONOPHARMACOLOGY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG POTENTIATION; HOT PLATE TEST; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PARALLEL DESIGN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REWARD; TEMPERATURE; WILD TYPE;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; MUSCARINIC ANTAGONISTS; PAIN MEASUREMENT; PAIN THRESHOLD; PIRENZEPINE; RECEPTOR, MUSCARINIC M1; REWARD;

EID: 33947180383     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0671-1     Document Type: Article

References (43)

1. Abe K, Taguchi K, Kato M, Utsunomiya I, Chikuma T, Hojyo H, Miyatake T (2003) Characterization of muscarinic receptor subtypes in the rostral ventrolateral medulla and effects on morphine-induced antinociception in rats. Eur J Pharmacol 465:237-249
2. Adem A, Jolkkonen M, Bogdanovic N, Islam A, Karlsson E (1997) Locations of M1 muscarinic receptors in rat brain using selective muscarinic toxin-1. Brain Res Bull 44(5):597-601
3. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, Sliva AJ (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6(1):51-58
4. Basile AS, Federova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J (2002) Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci 99 (17):11452-11457
5. Bolam JP, Francis CM, Henderson Z (1991) Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study. Neurosci 41:483-494
6. Brown JH, Taylor P (1996) Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics. McGraw-Hill, New York, pp 141-160
7. Caulfield MP (1993) Muscarinic receptors-characterization, coupling, and function. Pharmacol Ther 58:319-379
8. Caulfield MP, Birdsall NJ (1998) Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290
9. Cortes R, Palacios JM (1986) Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Brain Res 362:227-238
10. Eisenach JC (1999) Muscarinic mediated analgesia. Life Sci 64:549-554
11. Fink-Jensen A, Federova I, Wortwein G, Woldbye DPD, Rasmussen T, Thomsen M, Bolwig TG, Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A (2003) Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci 74:91-96
12. Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, Tonegawa S (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci 98(26):15312-15317
13. Ghelardini C, Galeotti N, Matucci R, Bellucci C, Gualtieri F, Capaccioli S, Quattrone A, Bartolini A (1999) Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice. Neuropharmacology 38:339-349
14. Glick SD, Cox RD (1975) Dopaminergic and cholinergic influences on morphine self-administration in rats. Res Commun Chem Pathol Pharmacol 12:17-24
15. Heidbreder CA, Shippenberg TS (1996) Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 24:182-192
16. Honda K, Ando S, Koga K, Takano Y (2004) The spinal muscarinic receptor subtypes contribute to the morphine-induced antinociceptive effects in thermal stimulation in mice. Neurosci Lett 371:235-238
17. Itzhak Y, Martin JL (2000) Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice. Psychopharmacology 152:216-223
18. Iwamoto ET, Marion L (1994) Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of the rat. J Pharmacol Exp Ther 269:699-708
19. Kaakola S, Ahtee L (1977) Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception, and changes in brain dopamine metabolism. Psychopharmacology 52(1):7-15
20. Koob GF (1992) Drugs of abuse: anatomy, pharmacology, and function of reward pathways. Trends Pharmacol Sci 13:177-184
21. Levey AI (1993) Immunological localization of M1-M5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448
22. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991) Identification and localization of muscarinic acetylcholine receptors in brain with subtype-specific antibodies. J Neurosci 11:3218-3226
23. Mash DC, Porter LT (1986) Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain. Neurosci 19(2):551-564
24. Miyakawa T, Yamada M, Duttaroy A, Wess J (2001) Hyperactivity and intact hippocampus dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21(14):5239-5250
25. Nathanson NM (1987) Molecular properties of the muscarinic acetylcholine receptor. Annu Rev Neurosci 10:195-236
26. Nonaka R, Moroji T (1984) Quantitative autoradiography of muscarinic cholinergic receptors in the rat brain. Brain Res 296:295-303
27. Oakman SA, Faris PL, Kerr PE, Cozzari C, Hortman BK (1995) Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-5869
28. Patterson TA, Lipton JR, Bennett EL, Rosenzweig MR (1990) Cholinergic receptor antagonists impair formation of intermediate-term memory in the chick. Behav Neural Biol 54(1):63-74
29. Ranaldi R, Woolverton W (2002) Self-administration of cocaine: scopolamine combinations by rhesus monkeys. Psychopharmacology 161:442-448
30. Schroeder JP, Packard MG (2002) Posttraining intra-basolateral amygdala scopolamine impairs food and amphetamine induced conditioned place preferences. Behav Neurosci 116(5):922-927
31. See RE, McLaughlin J, Fuchs RA (2003) Muscarinic receptor antagonism in the basolateral amygdale blocks acquisition of cocaine stimulus association in a model of relapse to cocaine seeking behavior in rats. Neurosci 117:477-483
32. Sperber ES, Romero MT, Bodnar RJ (1986) Selective potentiation in opioid analgesia following scopolamine treatment. Psychopharmacology 89(2):175-176
33. Spinella M, Schaefer LA, Bodnar RJ (1997) Ventral medullary mediation of mesencephalic morphine analgesia by muscarinic and nicotinic cholinergic receptor antagonists in rats. Analgesia 3:119-130
34. Vilaro MT, Palacios JM, Mengod G (1990) Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114:154-159
35. Vilaro MT, Mengod G, Palacios JM (1993) Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic recepots. Prog Brain Res 98:95-101
36. Weiner DM, Levey AI, Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-7054
37. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69-99
38. Wess J (2000) Physiological roles of G-protein-coupled receptor kinases revealed by gene-targeting technology. Trends Pharmacol Sci 21(10):364-367
39. Wess J, Buhl T, Lambrecht G, Mutschler E (1990) Cholinergic receptors. In: Emmett EC (ed) Comprehensive medicinal chemistry, vol 3. Pergamon, Oxford, pp 423-491
40. Wess J, Duttaroy A, Gomeza J, Zhang W, Yamada M, Felder CC, Bernardini N, Reeh PW (2003) Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review. Life Sci 72:2047-2054
41. Yeomans J, Forster G, Blaha C (2001) M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68(22-23):2449-2456
42. Zarrindast MR, Fattahi Z, Rostami P, Rezayof A (2005) Role of the cholinergic system in the rat basolateral amygdale on morphine-induced conditioned place preference. Pharmacol Biochem Behav 82(1):1-10
43. Zhou H, Ge X, Wang LZ, Ma L, Pei G (1999) Attenuation of morphine tolerance and dependence in scopolamine treated rats. Neuroreport 10(10):2007-2010